Bluejay Diagnostics, Inc.
$1.97
▲
3.17%
2026-04-21 05:40:01
bluejaydx.com
NCM: BJDX
Explore Bluejay Diagnostics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.94 M
Current Price
$1.97
52W High / Low
$16.68 / $1.65
Stock P/E
—
Book Value
$9.88
Dividend Yield
—
ROCE
-115.88%
ROE
-1.17%
Face Value
—
EPS
$-15.25
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
6
Beta
0.67
Debt / Equity
2.17
Current Ratio
4.88
Quick Ratio
4.88
Forward P/E
-5.56
Price / Sales
—
Enterprise Value
$-3.3 M
EV / EBITDA
0.48
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | PROCEPT BioRobotics Corporation | $25.73 | — | $1.45 B | — | -23.48% | -24.89% | $66.85 / $19.35 | $6.5 |
| 2. | Avanos Medical, Inc. | $24.64 | — | $1.15 B | — | 1.7% | -9.07% | $24.72 / $9.3 | $16.75 |
| 3. | Tivic Health Systems, Inc. | $1.13 | — | $3.25 M | — | -25.51% | -82.69% | $13.23 / $0.72 | $6.65 |
| 4. | iRhythm Holdings, Inc. | $124.91 | — | $4.04 B | — | -5.75% | -36.57% | $212 / $97.16 | $4.73 |
| 5. | Smith & Nephew plc | $32.71 | 22.84 | $14.01 B | 2.29% | 9.67% | 11.84% | $1,441.5 / $960.8 | $6.22 |
| 6. | Neuronetics, Inc. | $1.58 | — | $109.46 M | — | -28.31% | -1.35% | $4.85 / $0.8 | $0.32 |
| 7. | LivaNova PLC | $65.81 | — | $3.6 B | — | 11.09% | -19.24% | $71.92 / $34 | $21.96 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -1.46 M | -1.62 M | -1.99 M | -1.89 M | -1.48 M | — |
| Net Profit | -1.43 M | -1.6 M | -1.96 M | -1.86 M | -1.43 M | — |
| EPS in Rs | -1.38 | -1.54 | -1.89 | -1.8 | -1.38 | -307.76 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0.25 M |
| Operating Profit | -6.95 M | -7.17 M | -10.31 M | -9.32 M |
| Net Profit | -6.85 M | -7.72 M | -9.95 M | -9.3 M |
| EPS in Rs | -6.62 | -7.46 | -9.62 | -8.99 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 7.12 M | 6.66 M | 4.87 M | 13.52 M |
| Total Liabilities | 1.14 M | 0.93 M | 1.97 M | 1.98 M |
| Equity | 5.98 M | 5.73 M | 2.89 M | 11.54 M |
| Current Assets | 5.46 M | 4.9 M | 3.22 M | 11.79 M |
| Current Liabilities | 1.12 M | 0.81 M | 1.77 M | 1.64 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -6.05 M | -7.82 M | -8.31 M | -7.74 M |
| Investing CF | -0.17 M | -0.31 M | -0.7 M | -1.2 M |
| Financing CF | 7.09 M | 10.22 M | 1.11 M | 0.01 M |
| Free CF | -6.23 M | -8.13 M | -9.02 M | -8.94 M |
| Capex | -0.17 M | -0.31 M | -0.7 M | -1.2 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | -100% | — | — |
| Earnings Growth % | 22.46% | -7.07% | — | — |
| Profit Margin % | — | — | -3733.11% | — |
| Operating Margin % | — | — | -3741.48% | — |
| Gross Margin % | — | — | 19.64% | — |
| EBITDA Margin % | — | — | -3618.46% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-01-29 | 1:0.25 |
| 2024-11-18 | 1:0.02 |
| 2024-06-20 | 1:0.125 |
| 2023-07-24 | 1:0.05 |